Hoonmo Lee - 03 Aug 2021 Form 3 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role
Director, 10%+ Owner
Signature
/s/ Diana Douglas, as Attorney-in-Fact for Hoonmo Lee
Issuer symbol
INDP
Transactions as of
03 Aug 2021
Transactions value $
$0
Form type
3
Filing time
06 Aug 2021, 16:35:47 UTC
Next filing
06 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding INDP Common Stock 694,522 03 Aug 2021 see footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 694,522 shares of common stock held by TY Bio Investment, Inc. Mr. Lee shares investment authority over TY Bio Investment, Inc. Accordingly, Mr. Lee may be deemed to beneficially own the shares of Indaptus Therapeutics, Inc. common stock held by TY Bio Investment.